Drs. Jonathan Mizrahi and Shubham Pant discuss the importance of early supportive and palliative care in pancreatic cancer, where symptom burden and cachexia impact both quality of life and survival. Practical strategies such as pancreatic enzyme replacement and proactive symptom management are highlighted alongside emerging therapies targeting cancer cachexia. They also examine disparities in clinical trial access and reinforces the need for universal germline and molecular profiling as treatment options expand.
Contributors:
Dr. Jonathan Mizrahi is a medical oncologist with Ochsner Health in New Orleans, Louisiana.
Dr. Shubham Pant is a professor with the Department of Gastrointestinal Medical Oncology and Investigational Cancer Therapeutics at the University of Texas MD Anderson Cancer Center in Houston, Texas.
